1.Wang L, Ma L, Lin Y, Liu X, Xiao L, Zhang Y, Xu Y, Zhou H and Pan G*. Leflunomide increases hepatic exposure to methotrexate and its metabolite by differentially regulating multidrug resistance-associated protein Mrp2/3/4 transporters via peroxisome proliferator-activated receptor alpha activation. Mol Pharmacol. 93:563–574, 2018.
2.Shi X, Gao Y, Yan Y, Ma H, Sun L, Huang P, Ni X, Zhang L, Zhao X, Ren H, Hu D, Zhou Y, Tian F, Ji Y, Cheng X, Pan G*, Ding Y and Hui L. Improved survival of porcine acute liver failure by a bioartificial liver device implanted with induced human functional hepatocytes. Cell Res. 26:206-16. 2016.
3.Ni X, Gao Y, Wu Z, Ma L, Chen C, Wang L, Lin Y, Hui L and Pan G*. Functional human induced hepatocytes (hiHeps) with bile acid synthesis and transport capacities: A novel in vitro cholestatic model. Sci Rep. 6:38694. 2016.
4.Wu Z, Yao D, Ji SY, Ni X, Gao Y, Hui L and Pan G*. Optimized hepatocyte-like cells with functional drug transporters directly-reprogrammed from mouse fibroblasts and their potential in drug disposition and toxicology. Cell Physiol Biochem. 38:1815-30. 2016.
5.Ma L, Wu Z, Wang L, Zhang X, Wang J, Chen C, Ni X, Lin Y, Cao Y, Luan Y and Pan G*. Inhibition of hepatic cytochrome P450 enzymes and sodium/bile acid cotransporter exacerbates leflunomide-induced hepatotoxicity. Acta Pharmacol Sin. 37: 1– 10. 2016.
6.Sheng J, Tian X, Xu G, Wu Z, Chen C, Wang L, Pan L, Huang C, Pan G*. The Hepatobiliary disposition of timosaponin B2 is highly dependent on influx/efflux transporters but not metabolism. Drug Metab Dispos. 43(1): 63-72, 2015.
7.Chen C, Wu Z, Ma L, Ni X, Lin Y, Wang L, Chen K, Huang C, Pan G*.Organic anion-transporting polypeptides contribute to the hepatic uptake of berberine. Xenobiotica. 11: 1-9, 2015.
8.Guo C, He L, Yao D, A J, Cao B, Ren J, Wang G, Pan G*. Alpha-naphthylisothiocyanate modulates hepatobiliary transporters in sandwich cultured rat hepatocytes. Toxicol Lett. Volume 224, Issue 1, pp 93-100, 2014.
9.Tian X, Li Z, Lin Y, Chen M, Pan G*, Huang C*. Study on the PK profiles of magnoflorine and its potential interaction in Cortex phellodendri decoction by LC-MS/MS. Anal Bioanal Chem. Volume 406, Issue 3, pp 841-849, 2014.
10.He L, Yang Y, Guo C, Yao D, Liu H, Sheng J, Zhou W, Ren J, Liu X, Pan G*. Opposite regulation of hepatic breast cancer resistance protein in type 1 and 2 diabetes mellitus. Eur J Pharmacol. Volume 724, pp 185-92, 2014.